FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (CMP Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CMP Pharma's sodium polystyrene sulfonate under an ANDA, signaling an updated or expanded approval for this hyperkal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

SUPPL AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)